Aprecia Pharmaceuticals

Aprecia Pharmaceuticals company information, Employees & Contact Information

Aprecia offers commercial-scale production systems designed to accelerate clinical development and optimize commercial success. Our industry-leading 3DP formulation and manufacturing platforms transform drug development and delivery, meeting the unprecedented demand for complex and patient-friendly dosage forms. Aprecia joined with MIT Technology to build groundbreaking 3DP pharmaceutical technology with a mission towards advancing personalized medicine. With the first-of-its-kind innovations, Aprecia enables NDAs, extends product lifestyles, and accelerates clinical development. · Powder-based 3DP techniques use the widest set of ready materials compared to other additive manufacturing techniques. · The Binder Jetting technique provides the most flexibility when creating pharmaceutical formulations. · Aprecia is the first and only company in the world to obtain regulatory approval for a 3DP pharmaceutical product and utilized the MIT invented Binder Jetting technique to realize that feat. This transformed the use of 3DP from rapid prototyping in a laboratory setting to at scale production in a cGMP environment. Aprecia is a sister company of PRASCO The Leader In Authorized Generics and Trusted Pharmaceutical Partner Aprecia is poised to revolutionize pharmaceutical manufacturing through precision medicine and distributed manufacturing.

Company Details

Employees
63
Founded
-
Address
7200 Industrial Row Dr,
Phone
(513) 984-5000
Email
bi****@****cia.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Mason, Ohio
Looking for a particular Aprecia Pharmaceuticals employee's phone or email?

Aprecia Pharmaceuticals Questions

News

Resilience Through Innovation: Aprecia’s Role in Strengthening the U.S. Drug Supply Chain - Contract Pharma

Resilience Through Innovation: Aprecia’s Role in Strengthening the U.S. Drug Supply Chain Contract Pharma

Battelle and Aprecia Collaborate with U.S. Department of Health and Human Services (HHS) and U.S. Defense Advanced Research Projects Agency (DARPA) to Advance U.S. Drug Manufacturing Capability Utilizing 3D-Printed Technology to Produce Essenti - PR Newswire

Battelle and Aprecia Collaborate with U.S. Department of Health and Human Services (HHS) and U.S. Defense Advanced Research Projects Agency (DARPA) to Advance U.S. Drug Manufacturing Capability Utilizing 3D-Printed Technology to Produce Essenti PR Newswire

Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing - Newswire.com

Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing Newswire.com

DARPA Backs Battelle and Aprecia to Accelerate Pharmaceutical 3D Printing - 3DPrint.com

DARPA Backs Battelle and Aprecia to Accelerate Pharmaceutical 3D Printing 3DPrint.com

Battelle and Aprecia partner with DARPA to 3D print drugs - VoxelMatters

Battelle and Aprecia partner with DARPA to 3D print drugs VoxelMatters

Battelle and Aprecia Partner with DARPA to Advance Agile Pharmaceutical Manufacturing - 3D Printing Industry

Battelle and Aprecia Partner with DARPA to Advance Agile Pharmaceutical Manufacturing 3D Printing Industry

SPRITAM® (levetiracetam) Tablets for Oral Suspension Approved by FDA for Nasogastric and Gastrostomy Tube Administration - PR Newswire

SPRITAM® (levetiracetam) Tablets for Oral Suspension Approved by FDA for Nasogastric and Gastrostomy Tube Administration PR Newswire

FDA APPROVES THE FIRST 3D PRINTED DRUG PRODUCT - MultiVu

FDA APPROVES THE FIRST 3D PRINTED DRUG PRODUCT MultiVu

3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use - ScienceDirect.com

3D printing of gummy drug formulations composed of gelatin and an HPMC-based hydrogel for pediatric use ScienceDirect.com

Porous pills could be largest industrial 3D printing use - Chemistry World

Porous pills could be largest industrial 3D printing use Chemistry World

First drug produced by 3D printing is approved by FDA - News-Medical

First drug produced by 3D printing is approved by FDA News-Medical

Aprecia Release: First FDA-Approved Medicine Manufactured Using 3d Printing Technology Now Available - BioSpace

Aprecia Release: First FDA-Approved Medicine Manufactured Using 3d Printing Technology Now Available BioSpace

How Aprecia Pharma hopes to tackle patient noncompliance with 3-D printed drug - BioPharma Dive

How Aprecia Pharma hopes to tackle patient noncompliance with 3-D printed drug BioPharma Dive

Aprecia and Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation - PR Newswire

Aprecia and Battelle Are Impacting The Pharmaceutical Industry Through 3D Printing Innovation PR Newswire

Aprecia partners with Battelle to scale up 3D printed pharmaceutical manufacturing - 3D Printing Industry

Aprecia partners with Battelle to scale up 3D printed pharmaceutical manufacturing 3D Printing Industry

Aprecia Names Andrew Karazim as New Chief Commercial Officer - PR Newswire

Aprecia Names Andrew Karazim as New Chief Commercial Officer PR Newswire

Merck, Aprecia, and FabRx on transitioning 3D printed pharmaceuticals from lab to clinic - 3D Printing Industry

Merck, Aprecia, and FabRx on transitioning 3D printed pharmaceuticals from lab to clinic 3D Printing Industry

Kirk Donaldson joins Aprecia to Lead Global Business Development - PR Newswire

Kirk Donaldson joins Aprecia to Lead Global Business Development PR Newswire

Prasco Affiliate Acquires Larger Stake in Aprecia - PR Newswire

Prasco Affiliate Acquires Larger Stake in Aprecia PR Newswire

FDA Green Lights First 3D Printed Drug From Aprecia - BioSpace

FDA Green Lights First 3D Printed Drug From Aprecia BioSpace

Aprecia’s 3D Printed Epilepsy Drug is Finally Commercially Available - 3DPrint.com

Aprecia’s 3D Printed Epilepsy Drug is Finally Commercially Available 3DPrint.com

FDA signs off on first 3-D printed drug: Aprecia's quickly dissolving epilepsy tablet - Fierce Pharma

FDA signs off on first 3-D printed drug: Aprecia's quickly dissolving epilepsy tablet Fierce Pharma

Spritam (levetiracetam) for the Treatment of Epilepsy - Clinical Trials Arena

Spritam (levetiracetam) for the Treatment of Epilepsy Clinical Trials Arena

3D Printing Drugs: The Latest Advancements - All3DP

3D Printing Drugs: The Latest Advancements All3DP

Governo aprecia Programa Quinquenal 2025-2029 - MZNews

Governo aprecia Programa Quinquenal 2025-2029 MZNews

Top Aprecia Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant